Thermo Fisher Scientific (TMO) Total Current Liabilities (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Total Current Liabilities for 18 consecutive years, with $15.1 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities rose 18.49% year-over-year to $15.1 billion; the trailing twelve-month figure through Jun 2026 stood at $15.1 billion (up 18.49% YoY), and the FY2025 full-year result was $15.2 billion, up 13.93% from the prior year.
• Total Current Liabilities rose to $15.1 billion in Q2 2026 per TMO's latest filing, from $14.6 billion in the prior quarter.
• Across five years, Total Current Liabilities topped out at $17.0 billion in Q4 2022 and bottomed at $11.0 billion in Q3 2022.
• Historically, Total Current Liabilities has averaged $14.0 billion across 5 years, with a median of $14.1 billion in 2023.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities jumped 72.55% in 2022, then dropped 17.62% in 2023.
• Over 5 years, Total Current Liabilities stood at $17.0 billion in 2022, then fell by 17.62% to $14.0 billion in 2023, then decreased by 4.85% to $13.3 billion in 2024, then rose by 13.93% to $15.2 billion in 2025, then fell by 0.79% to $15.1 billion in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $15.1 billion, $14.6 billion, and $15.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.